Two Sigma Investments’s Halozyme HALO Stock Holding History

Two Sigma Investments’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-17,500	Closed	-$747K	–	3980
2020 Q4	$747K	Buy	+17,500	New	+$629K	﹤0.01%	2213
2018 Q2	–	Sell	-10,000	Closed	-$196K	–	3437
2018 Q1	$196K	Buy	+10,000	New	+$194K	﹤0.01%	2983

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments's HALO Position: Q1 2026 in Review

Two Sigma Investments increased its Halozyme (HALO) stake by 121% in Q1 2026, buying an estimated $61.2M and bringing the position to 1,584,961 shares worth $102M. The position accounts for 0.08% of the portfolio, ranked #273.

Two Sigma Investments first reported a position in HALO in Q2 2015 and has held it in 35 quarters since. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

Two Sigma Investments held 1,584,961 shares of Halozyme worth $102M as of Q1 2026.
Two Sigma Investments bought 867,592 Halozyme shares in Q1 2026, an estimated $61.2M.
Halozyme made up 0.08% of Two Sigma Investments's portfolio in Q1 2026, its #273 holding.
Two Sigma Investments first reported a position in Halozyme in Q2 2015 and has held it in 35 quarters since.
634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.